Semochkin, S.V. (2024) “Perspectives for the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma”, Clinical Oncohematology, 16(3), pp. 229–241. doi:10.21320/2500-2139-2023-16-3-229-241.